Novel approach to examining first cardiovascular events after hypertension onset
- PMID: 15545512
- DOI: 10.1161/01.HYP.0000149106.89470.13
Novel approach to examining first cardiovascular events after hypertension onset
Abstract
Hypertension confers risk for multiple types of cardiovascular events, but competing risks for these outcomes are unknown. We estimated the competing risks over 12 years after hypertension onset among cases and age-, sex-, and examination-matched controls using competing Cox cumulative incidence and proportional hazards models. We included all Framingham Heart Study subjects examined after 1977 with new-onset hypertension who were free of cardiovascular disease. There were 645 men and 702 women with new-onset hypertension (mean age: men, 55+/-12 years; women, 59+/-12 years). Compared with matched nonhypertensive controls, subjects with new-onset hypertension were more likely to experience a cardiovascular event first rather than noncardiovascular death. Among new-onset hypertensives, the 12-year competing cumulative incidence of any cardiovascular end point as a first event in men was 24.7%, compared with 9.8% for noncardiovascular death (hazards ratio [HR], 2.53; 95% confidence interval [CI], 1.83 to 3.50); in women, the competing incidences were 16.0% versus 10.1%, respectively (HR, 1.58; 95% CI, 1.13 to 2.20). The most common first major cardiovascular events were hard coronary disease (8.2%) in men and stroke (5.2%) in women. Type and incidence of first cardiovascular events varied by age and severity of hypertension at onset, with stroke predominating among older subjects with new-onset hypertension. After hypertension onset, cardiovascular events are more likely to occur first as opposed to noncardiovascular death. Types of initial events differ by gender, age, and severity of hypertension at onset. These results represent a novel approach to understanding the complications of hypertension and may help target therapies for patients with new-onset hypertension to optimize prevention strategies.
Similar articles
-
Risk of Cardiovascular Disease Associated with a Restless Legs Syndrome Diagnosis in a Retrospective Cohort Study from Kaiser Permanente Northern California.Sleep. 2015 Jul 1;38(7):1009-15. doi: 10.5665/sleep.4800. Sleep. 2015. PMID: 26083613 Free PMC article.
-
Sex differences in lifetime risk and first manifestation of cardiovascular disease: prospective population based cohort study.BMJ. 2014 Nov 17;349:g5992. doi: 10.1136/bmj.g5992. BMJ. 2014. PMID: 25403476 Free PMC article.
-
Hyperuricemia as a risk factor on cardiovascular events in Taiwan: The Chin-Shan Community Cardiovascular Cohort Study.Atherosclerosis. 2005 Nov;183(1):147-55. doi: 10.1016/j.atherosclerosis.2005.01.018. Epub 2005 Sep 8. Atherosclerosis. 2005. PMID: 16154134
-
Prognostic interactions between cardiovascular risk factors.Dan Med J. 2014 Jul;61(7):B4892. Dan Med J. 2014. PMID: 25123126 Review.
-
Incidence and epidemiology of heart failure.Heart Fail Rev. 2000 Jun;5(2):167-73. doi: 10.1023/A:1009884820941. Heart Fail Rev. 2000. PMID: 16228142 Review.
Cited by
-
Dietary nitrate supplementation and small muscle mass exercise hemodynamics in patients with essential hypertension.J Appl Physiol (1985). 2022 Aug 1;133(2):506-516. doi: 10.1152/japplphysiol.00218.2022. Epub 2022 Jul 14. J Appl Physiol (1985). 2022. PMID: 35834624 Free PMC article.
-
Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people.Lancet. 2014 May 31;383(9932):1899-911. doi: 10.1016/S0140-6736(14)60685-1. Lancet. 2014. PMID: 24881994 Free PMC article. Clinical Trial.
-
Cardiac target organ damage in hypertension: insights from epidemiology.Curr Hypertens Rep. 2014 Jul;16(7):446. doi: 10.1007/s11906-014-0446-8. Curr Hypertens Rep. 2014. PMID: 24801135 Free PMC article. Review.
-
Monitoring vascular health beyond blood pressure.Curr Hypertens Rep. 2006 Aug;8(4):287-91. doi: 10.1007/s11906-006-0066-z. Curr Hypertens Rep. 2006. PMID: 16884658 Review.
-
A review of the phytochemistry and pharmacological activities of raphani semen.Evid Based Complement Alternat Med. 2013;2013:636194. doi: 10.1155/2013/636194. Epub 2013 Jul 8. Evid Based Complement Alternat Med. 2013. PMID: 23935670 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical